ASP8477

DRUG2 trials

Sponsors

Astellas Pharma Europe B.V.

Conditions

Neuropathic PainPainful Diabetic Peripheral Neuropathy (PDPN)Pharmacodynamics of ASP8477Pharmacokinetics of ASP8477Post-Herpetic Neuralgia (PHN)

Phase 1

A Study to Assess the Effects of Single Ascending Doses (SAD) of ASP8477, the Effect That Food Has on the Drug, and the Interaction Between ASP8477 and Omeprazole in Healthy Postmenopausal Females and Healthy Young Vasectomized Males

CompletedNCT02220777

Astellas Pharma Europe B.V.Pharmacodynamics of ASP8477, Pharmacokinetics of ASP8477

Start: 2010-11-30End: 2011-05-31Updated: 2014-08-20

Phase 2

A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety

CompletedNCT02065349

Astellas Pharma Europe B.V.Neuropathic Pain, Painful Diabetic Peripheral Neuropathy (PDPN), Post-Herpetic Neuralgia (PHN)

Start: 2014-02-24End: 2015-02-13Updated: 2017-11-08